Previous Article | Next Article 
Molecular and Cellular Biology, April 2001, p. 2671-2682, Vol. 21, No. 8
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.8.2671-2682.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Repair of Double-Strand Breaks by Homologous Recombination in
Mismatch Repair-Defective Mammalian Cells
Beth
Elliott and
Maria
Jasin*
Cell Biology Program, Memorial
Sloan-Kettering Cancer Center and Cornell University Graduate
School of Medical Sciences, New York, New York 10021
Received 7 December 2000/Returned for modification 9 January
2001/Accepted 31 January 2001
 |
ABSTRACT |
Chromosomal double-strand breaks (DSBs) stimulate homologous
recombination by several orders of magnitude in mammalian cells, including murine embryonic stem (ES) cells, but the efficiency of
recombination decreases as the heterology between the repair substrates
increases (B. Elliott, C. Richardson, J. Winderbaum, J. A. Nickoloff, and M. Jasin, Mol. Cell. Biol. 18:93-101, 1998). We have
now examined homologous recombination in mismatch repair (MMR)-defective ES cells to investigate both the frequency of recombination and the outcome of events. Using cells with a targeted mutation in the msh2 gene, we found that the barrier to
recombination between diverged substrates is relaxed for both gene
targeting and intrachromosomal recombination. Thus, substrates with
1.5% divergence are 10-fold more likely to undergo DSB-promoted
recombination in Msh2
/
cells than in
wild-type cells. Although mutant cells can repair DSBs efficiently,
examination of gene conversion tracts in recombinants demonstrates that
they cannot efficiently correct mismatched heteroduplex DNA (hDNA) that
is formed adjacent to the DSB. As a result, >20-fold more of the
recombinants derived from mutant cells have uncorrected tracts compared
with recombinants from wild-type cells. The results indicate that gene
conversion repair of DSBs in mammalian cells frequently involves
mismatch correction of hDNA rather than double-strand gap formation. In
cells with MMR defects, therefore, aberrant recombinational repair may
be an additional mechanism that contributes to genomic instability and
possibly tumorigenesis.
 |
INTRODUCTION |
Caretaker genes, such as the genes
in the mismatch repair (MMR) and nucleotide excision (NER) pathways,
are involved in the repair of DNA lesions (6, 12). Loss of
function of a caretaker gene can result in a mutator phenotype, thus
allowing the numerous mutations necessary for tumorigenesis to
accumulate. Such a mutator phenotype is now seen as an important
contributor to tumorigenesis (23, 27, 34). Defects in MMR
lead to the inherited cancer syndrome hereditary nonpolyposis
colorectal cancer (HNPCC) and possibly to a small proportion of
sporadic colorectal cancers (references 5 and
6 and references therein), while defects in NER lead to
xeroderma pigmentosum (12). In HNPCC, an autosomal dominant disease, one mutated allele of a gene involved in MMR is
inherited and a somatic mutation occurs in the remaining wild-type allele, thus promoting colorectal cancer. Mutations in two MMR genes,
MSH2 and MLH1, have been typically associated
with HNPCC, while mutations in other MMR genes (MSH6, PMS1,
and PMS2) are rarer. HNPCC tumors have frequent length
alterations of microsatellites, such as contractions or expansions of
mononucleotide repeats, which is referred to as microsatellite
instability and which is due to the lack of repair of slipped
replication intermediates.
The MMR pathway is a conserved pathway which maintains genomic
integrity in procaryotes and eucaryotes. The Escherichia
coli MutHLS MMR pathway has been well-characterized genetically
and biochemically (37) and has served as a paradigm for
the yeast and mammalian MMR pathways (reviewed in reference
6). A number of homologs of MutS and MutL have been found
in yeast and mammalian cells. The MutS homologs Msh2 and Msh6 form a
heterodimer known as MutS
that functions in the repair of
single-base mismatches and small (1 bp) insertion-deletion loops
(16, 25). Msh2 also pairs with another MutS homolog, Msh3,
to form a heterodimer known as MutS
, which is involved in the repair
of larger (2 to 4 bp) insertion-deletion loops (2, 35).
Msh2, therefore, plays a central role in eucaryotic MMR since it is
responsible for the repair of all mismatches, while Msh6 and Msh3 act
to determine the specific types of mismatches that are recognized.
In addition to their role in the repair of replication errors, MMR
components have been implicated in a second DNA repair pathway,
homologous recombination. In mammalian cells, as in other organisms,
homologous recombination is well-established as one of the major
pathways for the repair of DNA double-strand breaks (DSBs) (32,
40). As a result of its role in DSB repair, homologous recombination is stimulated 2 to 3 orders of magnitude by a DSB in the
genome (33, 48, 50). We have found that the frequency of
DSB-induced recombination in mammalian cells can be affected by
relatively small degrees of sequence heterology (17). For example, recombination is decreased by approximately sixfold between sequences that are 1.2% divergent. During recombination, a gene conversion tract (GCT) around the DSB is formed, where there is a
unidirectional transfer of sequence information from the unbroken donor
DNA molecule to the broken DNA molecule. In principal, gene conversion
can result from either mismatch correction of heteroduplex DNA (hDNA)
or from the processing of a DSB to a gap, such that the only
information available is from the donor DNA molecule. In yeast,
chromosome ends at DSBs appear to be highly protected (21), such that most DSB-induced gene conversion involves
mismatch correction of hDNA (44, 58).
MMR components function in recombination by suppressing recombination
between diverged (homologous) sequences, a role that appears to be
conserved in bacteria, yeast, and in mammalian cells (reviewed in
reference 37). For example, E. coli strains
deficient for MutS or MutL have lost the barrier to recombination
between diverged sequences on the same chromosome as well as between
genera, resulting in chromosomal rearrangements and intergeneric
crosses, respectively (43, 45). As a result, these
MMR-deficient strains exhibit a "recombinator phenotype" in
addition to their well-characterized mutator phenotype, thus
contributing an additional level of genetic instability to these
mutants. Similarly, in Saccharomyces cerevisiae, loss of MMR
proteins significantly increases homeologous recombination between
direct repeats (8, 10, 11, 52), as well gene targeting of
homeologous sequences (29, 39).
In mammals, Msh2-deficient embryonic stem (ES) murine cells
have been shown to be promiscuous for recombination between diverged sequences in gene-targeting experiments (1, 13). This role of MMR proteins in suppressing recombination between homeologous sequences may be particularly important in mammalian cells, since repetitive elements are naturally occurring diverged sequences that
make up a large fraction of mammalian genomes. For example, human cells
contain approximately 106 copies of Alu
elements, which are around 300 bp and are 70 to 98% homologous to the
consensus Alu sequence (51). Although rare,
Alu-Alu-mediated recombination has been reported for many diseases with deleterious consequences (reviewed in reference 9), such as in acute myeloid leukemia, where recombination between two diverged Alu elements in the ALL1
gene results in a partial gene duplication (54).
The large stimulation of recombination by DSBs led us to investigate
the effect of MMR deficiency on DSB-induced recombination in mammalian
cells. In this report, we investigate Msh2
/
ES cells for DSB-induced gene-targeting and intrachromosomal recombination between diverged substrates. Both the frequences of
recombination and the GCTs are examined, the latter so as to determine
whether gene conversion at a DSB occurs primarily by gap repair or MMR
of hDNA. Our goal is to begin to ascertain what genomic alterations in
addition to unrepaired replication errors could be potentiated in
MMR-deficient cells, which may therefore have implications for
tumorigenesis in HNPCC.
 |
MATERIALS AND METHODS |
DNA and cell line constructions.
Construction of the pneo
gene-targeting plasmids, pneo-WT, pneo-5mu, and pneo-8mu, has been
described previously (17). The pneo-10mu substrate was
made by PCR-induced site-directed mutagenesis as follows: the pneo-8mu
plasmid was amplified with primer 1B (5'CAGTCGATGAATCCGGAAAAGCGGCCAT) and primer 4 (5'ACCATGATTACGCCAAGCTT) and with primer 2B
(5'CCGCTTTTCCGGATTCATCGACTGTGGC) and primer 3 (5'TGCTCGACGTTGTCACTGAA). The integrity of the
neo sequence of the pneo-10mu plasmid was checked in both
directions with three primers (Bio Resource Center, Cornell University,
Ithaca, N.Y.). To make the intrachromosomal constructs, the 0.8-kb
SacI-XbaI fragments derived from the pneo-WT and
pneo-8mu plasmids were subcloned into the S2neo/pgkhygo
plasmid (33). The pgkhygro gene was replaced by
a puro gene (26) from pHA262pur (a kind gift of
Hein te Riele, Netherlands Cancer Institute, Amsterdam, The
Netherlands). A 1.6-kb PvuII-PvuII fragment of
the HPRT gene from pGPD351 (15) and a 2.3-kb
XbaI-XbaI fragment of the HPRT gene
from the same plasmid were subcloned to flank the
S2neo/pgkpuro/pneo repeat, forming 5' and 3' targeting arms, respectively.
Cell culture and transfections.
The
Msh2
/
mutant cell line dMsh2-9 (a kind gift
of Hein te Riele) was derived from the E14 ES cell line, which served
as a control in our experiments and has both alleles of msh2
disrupted by the hyg marker (13). All cells
were cultured on gelatin-coated dishes in standard medium supplemented
with 103 U of leukemia inhibitory factor (GIBCO/Life
Technologies)/ml as previously described (47). For the
construction of cell lines for gene-targeting assays, the
Msh2
/
mutant cells were electroporated with
60 µg of the S2neo gene on a plasmid along with 20 µg of
a plasmid containing the pgk-puro gene. Doubly resistant
hyg and puro colonies were isolated and tested by
Southern blot analysis for the presence of a single copy of
S2neo. Possibly integrated into the genome of wild-type and
Msh2
/
cells adjacent to the S2neo
gene are bacterial vector sequences which would have homology to vector
sequences in the pneo gene-targeting plasmids. This homology would be
interrupted, however, by sequences unique to the S2neo gene,
since it extends 0.3 kb 5' and 0.1 kb 3' beyond the pneo homology. For
the construction of cell lines for the intrachromosomal recombination
assays, the H-DR-WT and the H-DR-8mu constructs were integrated into
the HPRT locus in murine ES wild-type and
Msh2
/
cells by electroporation of 15 to 20 µg of the SacI-XhoI-digested H-DR-WT (or 8mu)
construct. Colonies were selected in 6-thioguanine and puromycin, and
the resulting cell lines were checked by Southern blot analysis, as
shown, for the correct integration of the construct.
For each sample of cells in the gene-targeting and intrachromosomal
recombination assays, 2 × 107 cells in 1 ml of
phosphate-buffered saline were electroporated with 20 to 25 µg of
each uncut plasmid DNA in a 0.4-cm electrode-gap cuvette (250 V, 960 µF). Electroporated cells were aliquoted into four or five
10-cm-diameter dishes. Colonies were selected in media with one or more
of the following drugs 20 to 24 h after electroporation and were
grown in selection media for 10 to 14 days before colony counts (or
after colony expansion): G418 (200 µg/ml), hygromycin (150 µg/ml),
puromycin (1.6 µg/ml), or 6-thioguanine (4 µg/ml).
PCR analysis.
A region of the chromosomal neo
gene in neo+ intrachromosomal recombinants from
wild-type and Msh2
/
cells containing the
H-DR-8mu construct was PCR amplified with primers Neol
(5'GCCAATATGGATCGGCCATTGAACAA) and Neo3
(5'CCTCAGAAGAACTCGTCAAGA). Amplification was performed by
denaturation at 94°C for 3 min, followed by 30 cycles of 94°C for 1 min, 58°C for 1 min, and 72°C for 1 min, and then extension at
72°C for 15 min. Amplified products were digested with
I-SceI and appropriate restriction enzymes and were
electrophoresed on 2% agarose gels (25% agarose-75% Nusieve agarose).
 |
RESULTS |
Gene targeting with diverged repair substrates in wild-type and
Msh2
/
ES cells.
We have previously
found in a gene-targeting assay with wild-type ES cells that the
efficiency of homologous repair of a DSB decreases as the divergence of
the homologous repair substrate increases (17). Using the
same assay, we wanted to determine whether the effects of heterology
would be overcome in an MMR-deficient genetic background. The
gene-targeting assay consists of three components: a chromosomally
integrated nonfunctional neo gene (termed S2neo)
which contains the 18-bp I-SceI endonuclease cleavage site,
diverged neo repair substrates on circular plasmids, and an
expression plasmid for the I-SceI endonuclease (Fig.
1). With this design, a DSB introduced
into the S2neo gene at the I-SceI site can be
repaired from the homologous repair substrates to restore a
neo+ gene.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 1.
DSB-induced gene-targeting strategy. The
S2neo gene which is integrated into the genome of wild-type
and Msh2 / murine ES cells contains the 18-bp
I-SceI site (thick vertical bar) which can be cleaved in
vivo by the I-SceI endonuclease. The S2neo
promoter (arrow) is derived from polyomavirus (strain F441) and the
herpesvirus thymidine kinase gene (55). The repair
substrates are internal neo sequences which are 745 bp in
length. The percent divergence of each of these sequences relative to
the same region in S2neo is indicated. For simplicity,
heterology at the NcoI-I-SceI sites is
considered to be one change within the 745-bp segment, although
recombination involves loss of the 18-bp cleavage site at this position
and a gain of 4 bp at the NcoI site (17).
Silent mutations create the following restriction enzyme site
polymorphisms in the neo sequence: A, ApaI; L,
ApaLI; P, PstI; B, BamHI; X,
XbaI; Nr, NruI; Ns, NsiI; Bs,
BspEI; Na , loss of NaeI; Pm,
PmlI. Note that there is a naturally occurring
PstI site within the neo sequence. Distances (in
base pairs) between the 1-bp silent mutations are indicated. For
DSB-induced gene targeting, an expression vector for the
I-SceI endonuclease and a repair substrate on a plasmid are
transfected into wild-type and Msh2 / cells
containing the S2neo gene. One example of the type of
analysis after recombination is shown after targeting with pneo-8mu.
Since a neo+ gene is selected, the correcting
neo gene sequence at the NcoI site has been
incorporated. As recombination may occur with or without conversion of
adjacent sequences, the presence of the 8 silent mutations (?) was
determined by restriction analysis.
|
|
The repair substrates, which diverged from
S2neo in the
range of 0.1 to 1.5%, each consist of an internal
neo gene
fragment
restricting selected recombination events to noncrossover gene
conversions. Each substrate had the correcting
NcoI site at
the
position of the I-
SceI site in the
S2neo
gene. Divergence was
created in the 745-bp
neo fragments by
substitutions at third-base
codon positions that create phenotypically
silent mutations as
well as restriction enzyme site polymorphisms
(
56). Plasmids
pneo-5mu and pneo-8mu have
neo
gene fragments with five and eight
silent mutations, respectively, as
described previously (
17).
A new repair substrate with
more divergence was created for this
study by the addition of two
silent mutations downstream of the
NcoI and
NsiI
sites in pneo-8mu. With this new substrate, called
pneo-10mu, there
were similar densities of heterology both 5'
and 3' of the correcting
NcoI
site.
For our assays, we used two wild-type ES cell lines, clones 12 and 5, each of which have a single copy of the
S2neo gene randomly
integrated into the genome (53; data not shown). To create
Msh2
/
ES cell lines containing the
S2neo gene, we cotransfected the
S2neo gene on a
plasmid along with the puromycin
N-acetyltransferase
gene
(
pgk-puro) on a separate plasmid into
Msh2-deficient ES cells
which had both alleles of the
msh2 gene disrupted by the hygromycin
(
hyg)
resistance gene (
13). Cells were selected in both
puromycin
and hygromycin, and 28 doubly resistant colonies were
isolated.
Colonies were screened by Southern blotting for the presence
of
a single copy of the
S2neo gene (data not shown). Four
independent
Msh2
/
cell lines obtained in
this screen (termed clones 14, 18, 28,
and 30) were used in subsequent
analysis.
Effect of heterology on the frequency of gene targeting.
To
examine the effect of heterology on DSB-induced gene targeting,
wild-type and Msh2
/
cell lines were
electroporated with the I-SceI expression vector pPGK3xnlsI-SceI and each of the pneo repair substrates. As
controls, cells were electroporated with these plasmids separately, and cells were also electroporated with pMC1neo, a plasmid containing a
functional neo gene. Cells were selected with G418, and
neo+ (G418r) recombinant colonies
were scored 10 to 14 days later. Control electroporations of the
I-SceI expression vector or any of the pneo repair
substrates alone yielded very few or no neo+
clones from any of the cell lines (
10
7), yet
neo+ clones were readily obtained from
electroporations of the two plasmids together (Table
1; data not shown). As previously seen with the pneo-WT substrate, DSBs resulting from I-SceI
expression stimulated gene targeting more than 3 orders of magnitude in
the wild-type ES cells (17). This large increase in
stimulation was also observed in the Msh2
/
cells. The absolute frequency of targeting was subject to some clonal
variation, but overall the range of gene-targeting frequencies with
pneo-WT was similar for both wild-type and Msh2
parental cell lines (Table 1).
By examining DSB-promoted recombination with the diverged substrates,
we found that in wild-type cells, the frequency of
neo+ clones decreased as the repair substrates
became more diverged
from the
S2neo gene (Table
1). The mean
decrease in frequency
from that of pneo-WT was 2.2-fold for pneo-5mu
(0.8% divergent)
and 4.8-fold for pneo-8mu (1.2% divergent) (Fig.
2), similar to
previous results
(
17). Recombination with pneo-10mu (1.5% divergent)
was
even more dramatically decreased, i.e., by 16.7-fold. Thus,
the
addition of two silent mutations in the 101-bp stretch of
perfect
homology just downstream of the DSB significantly decreased
the
frequency of recombination.

View larger version (37K):
[in this window]
[in a new window]
|
FIG. 2.
Relative gene-targeting efficiencies of diverged
substrates. The frequency of neo+ colonies after
DSB-induced recombination was plotted for cell lines transfected with
each of the diverged pneo substrates relative to frequencies of cell
lines transfected with the pneo-WT substrate. In each case, the
transfection included pPGK3xnlsI-SceI to induce a DSB at the
S2neo gene. The means of seven independent experiments are
shown with error bars indicating the standard deviations. WT, wild
type.
|
|
In contrast to results obtained with wild-type ES cells, in
Msh
/
cells, the frequencies of
neo+ colonies obtained with each of the three
diverged repair substrates
were only slightly reduced from the
frequency obtained with the
pneo-WT control (Table
1). Substrates
pneo-5mu and pneo-8mu had
mean decreases of 1.2- and 1.5-fold in the
frequency of recombination,
respectively, while pneo-10mu had only a
1.7-fold decrease. Thus,
Msh2
/
cells had
10-fold more recombination with pneo-10mu relative
to recombination
with pneo-WT than did wild-type cells, threefold
more recombination
with pneo-8mu, and twofold more recombination
with pneo-5mu (Fig.
2).
Clearly, the barrier to recombination
imposed by heterology is
significantly overcome in
Msh2-deficient
cells.
Intrachromosomal recombination with diverged repair substrates in
wild-type and Msh2
/
ES cells.
Gene
targeting provides a rapid assay to evaluate the effect of sequence
divergence, but a limitation is that one of the recombining partners is
on a plasmid. We therefore decided to examine the effect of sequence
divergence in a more physiological setting in which both neo
partners would be integrated in chromosomal DNA. For this, we
constructed intrachromosomal recombination substrates and examined both
the frequency and products of recombination. So as to eliminate
possible position effects on recombination, we integrated the
neo genes at the same chromosomal locus in wild-type and
Msh2
/
cells. The locus we chose for
integration is the X-linked hypoxanthine phosphoribosyltransferase
(HPRT) locus since integrations which disrupt the
HPRT gene can be selected in XY murine ES cells by using the
base analog 6-thioguanine.
The site of integration at the
HPRT locus and the
intrachromosomal recombination substrates are shown in Fig.
3A. The recombination
substrates
contained the
S2neo gene and a repair template derived
from
a pneo plasmid, which were oriented as direct repeats and
separated by
the
pgk-puro gene. Two recombination substrates were
constructed which differed by the pneo-derived repair substrate.
In the
control, H-DR-WT (HPRT-direct repeat-pneo-WT), the internal
neo fragment was derived from pneo-WT, whereas in the test
construct
H-DR-8mu (HPRT-direct repeat-pneo-8mu), it was derived from
pneo-8mu.
As in the gene-targeting experiments, DSB-promoted
recombination
between an I-
SceI-cleaved
S2neo
gene and the internal
neo fragment
resulted in a
neo+ gene. Because crossover in these
intrachromosomal recombination
substrates would have resulted in a
truncated
neo gene, only recombinants
which had undergone a
noncrossover gene conversion were selected,
thus simplifying the
interpretation of our results to one repair
pathway.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 3.
Intrachromosomal recombination substrates integrated at
the HPRT locus. (A) The HPRT locus at exons 2 and
3 is shown along with gene-targeted HPRT loci containing
intrachromosomal repair substrates. The H-DR-WT substrate contains a
direct neo repeat of S2neo and pneo-WT, and the
H-DR-8mu substrate contains a direct neo repeat of
S2neo and pneo-8mu (Fig. 1). Separating the neo
repeat in both substrates is a pgk-puro gene for selection.
Repair substrates were cloned into the PvuII (Pv) and
XbaI (X) sites of the HPRT locus, as indicated,
using XhoI (Xh) and XbaI sites of the substrates,
and this deleted exon 2. Distances between the BamHI (B) and
HindIII (H3) sites are shown in kilobases. Neo1 and Neo3
indicate the primers used for PCR amplification. Neo1 has no overlap
with pneo-8mu, and Neo3 has an overlap of 6 nucleotides. (B) Southern
blot analysis of BamHI-HindII-digested
genomic DNA indicated that the intrachromosomal substrates were
correctly targeted and had integrated as a single copy in the wild-type
and Msh2 / cell lines. The probe was a 1.1-kb
XhoI-HindIII fragment containing the entire
neo+ gene. Genomic DNA from parental wild-type
and Msh2 / cells did not hybridize with this
probe, as expected (data not shown).
|
|
The intrachromosomal recombination substrates were electroporated into
wild-type and
Msh2
/
ES cells. Cells were
selected in puromycin and 6-thioguanine,
and doubly resistant colonies
were picked 10 to 14 days later.
Clones were examined by Southern
blotting, and the majority (83%)
had correctly integrated the
substrates into the
HPRT locus (Fig.
3B). For each of the
wild-type and
Msh2
/
ES cell lines, two or
three clones containing the H-DR-WT or
H-DR-8mu constructs were further
characterized.
Effect of heterology on the frequency of intrachromosomal
recombination.
To examine homologous recombination between the two
neo repeats, cells were electroporated with the
I-SceI expression vector or a control vector, pPGKlacZ.
Selection was in medium containing G418, and G418r
(neo+) colonies were isolated 10 to 14 days
later. Results from these experiments are shown in Table
2. As with gene targeting, DSBs induced
intrachromosomal recombination in both wild-type and
Msh2
/
ES cells, resulting in a similar
frequency of recombination for both cell lines. The absolute
frequencies of DSB-induced intrachromosomal recombination and gene
targeting with the pneo-WT repair substrate were similar (approximately
2 × 10
4). However, since the spontaneous level of
intrachromosomal recombination was readily detectable, unlike in our
gene-targeting assay, DSBs stimulated intrachromosomal recombination
only about 2 orders of magnitude, rather than the >3 orders of
magnitude seen in the gene-targeting experiments.
In wild-type cells, sequence divergence led to a significant decrease
in both break-induced and spontaneous recombination.
For break-induced
recombination, the frequency of
neo+ colonies
obtained from clones containing the H-DR-8mu substrate
(1.2%
divergent) relative to those containing the control H-DR-WT
substrate
(0.1% divergent) decreased by 4.5-fold (Table
2). The
frequency of
spontaneous recombination was also decreased, approximately
12-fold,
although the decrease in the rate of recombination has
not been
measured. In
Msh2
/
cells, the frequency of
neo+ colonies arising from transfection of the
I-
Sce I expression
vector was not substantially different
between cell lines containing
the H-DR-WT and H-DR-8mu substrates, nor
did the spontaneous recombination
frequency differ. Thus, there is
little barrier to both DSB-promoted
and spontaneous recombination from
sequence divergence in the
absence of the MMR
pathway.
GCTs from intrachromosomal neo+
recombinants.
During DSB repair, gene conversion can occur by
mismatch correction of hDNA, by repair of a gap formed around the break
site, or by a combination of both mechanisms. In wild-type cells,
mismatches in hDNA would be expected to be corrected rapidly, resulting
in daughter cells with an identical genotype. In
Msh2
/
cells, however, mismatches in hDNA
would be expected to remain uncorrected. Segregation of mismatches
after replication and cell division would produce daughter cells with
two different genotypes (Fig. 4A),
similar to postmeiotic and postmitotic segregation found in yeast
(36, 42, 44). Since cells were plated immediately after
electroporation of the I-SceI expression vector, both
daughter cells from a recombinant cell should have been represented in a neo+ colony. Unlike mismatch correction of
hDNA, however, repair of a double-stranded gap is entirely dependent on
sequence information from the homologous repair template. Therefore,
gap repair involving a particular silent mutation would be expected to
lead to complete conversion in both Msh2
/
and wild-type cells, resulting in neo+ colonies
with a single genotype.

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 4.
Analysis of DSB-induced intrachromosomal
recombination in wild-type and Msh2 / cell
lines. (A) After in vivo expression of the I-SceI
endonuclease, a DSB was introduced in the S2neo gene (top
bar) of the H-DR-8mu substrate. Recombinational repair was initiated
using the pneo-8mu template (bottom bar), restoring the NcoI
site at the former position of the I-SceI site (thick hatch
marks) to form a neo+ gene and, in this case,
creating hDNA at the downstream NsiI and PmlI
restriction site polymorphisms (thin hatch marks). Correction of the
mismatched hDNA in a wild-type cell, followed by replication and
division, results in both daughter cells containing the same genotype.
However, in Msh2 / cells, MMR correction does
not occur, and the uncorrected strands are segregated to daughter
cells. (B) PCR analysis of two neo+ clones after
DSB-induced recombination in the H-DR-8mu substrate. The
neo+ gene coding region was amplified by PCR as
an 810-bp fragment from genomic DNA with primers Neo1 and Neo3 and
electrophoresed on agarose gels following digestion with the indicated
restriction enzymes (Fig. 3). The amplified product from each of the
neo+ clones was not cleaved by I-SceI
(data not shown) but was cleaved by NcoI (Nco) and other
restriction enzymes, as indicated by arrows. In the wild-type
recombinant 3A-10, the NsiI (Ns) and PmlI (Pm)
sites were fully cleaved, indicating a population of cells with one
genotype (as in lane A). By contrast, in the
Msh2 / recombinant 17A-9, both the
NsiI and the PmlI sites were partially cleaved,
indicating a population of cells with two genotypes (as in lane A).
Note that due to the naturally occurring PstI (P) site, the
amplified fragment in each of the clones was shifted when cleaved with
PstI. M, mixed digest; MW, 1-kb ladder molecular weight
marker; A, ApaI; L, ApaLI; B, BamHI;
X, XbaI; Nr, NruI.
|
|
To gain insight into mechanisms of gene conversion, we analyzed (GCTs)
of
neo+ recombinants obtained from our
intrachromosomal recombination
assays. The recombinants were derived
from transfection of the
I-
SceI expression vector into
clones containing the H-DR-8mu construct.
Genomic DNA was isolated from
each of the recombinants, and PCR
was performed to amplify the
converted
S2neo (now
neo+) gene. The
neo primers used in this analysis flanked the position
of
the DSB site and were mainly outside the region of homology
of pneo-8mu
so as not to amplify the donor repair substrate (Fig.
3). PCR products
were digested with restriction enzymes corresponding
to the silent
mutations in the repair substrate to determine which
of the silent
mutations had been incorporated into the
neo+
gene after gene
conversion.
PCR analysis for two recombinants is shown in Fig.
4B. Products from
both recombinants were completely cleaved by
NcoI, as
was
expected since these clones are G418 resistant, indicating
that
neo gene function was restored. The incorporation of the
NcoI site required the loss of heterology from the
I-
SceI site,
5 bp from the 5' side and 9 bp from the 3' side
plus the 4-base
overhang on each side. In addition to the
NcoI site, the PCR product
from the recombinant derived from
wild-type ES cells was also
completely cleaved by
NsiI and
PmlI, enzymes which have restriction
sites 3' of the
NcoI site. Thus, this clone had an observed GCT
of 114 bp.
This is a unidirectional GCT, as none of the six polymorphisms
5' of
the
NcoI site was incorporated. (The PCR product was also
cleaved by
PstI at the naturally occurring site 5' of the
NcoI
site which is present in both the
S2neo gene
and the pneo-8mu
repair substrate but was not cleaved at the
polymorphic
PstI site
present only in pneo-8mu.) The
recombinant derived from the
Msh2
/
cell line
had a PCR product which was partially cleaved by
NsiI
and
PmlI. This implies that a small gap of less than 8 bp formed
on the 3' side of the I-
SceI cleavage site (i.e., 7 bp plus
the
1-bp silent mutation at the
NsiI site; Fig.
1). In
addition, it
implies that hDNA was present at the position of the
NsiI site
(8 bp from the I-
SceI site) as well as
that of the
PmlI site (102
bp from the I-
SceI
site) but that as a result of the MMR deficiency
the hDNA remained
uncorrected and segregated to daughter
cells.
A summary of GCTs from 80
neo+ recombinants that
were analyzed is presented in Fig.
5.
Each of the recombinants from both cell
lines had lost the
I-
SceI site and had acquired the
NcoI site.
Flanking restriction site polymorphisms in recombinants from the
wild-type cells, with one exception, were either completely cleaved
or
completely uncleaved by the diagnostic restriction enzymes
(Fig.
5A).
This indicated that daughter cells derived from the
initial recombinant
cell contained the same genotype. In the one
exception, one of the two
polymorphic restriction sites incorporated
into the recombinant
(
NruI) was partially cleaved. The GCTs were
generally short.
The majority (80%) of the observed GCTs in the
recombinants were 58 bp
or less, maximally incorporating the two
mutations nearest the
NcoI site (
NsiI and
NruI), although
two
tracts were observed to be as long as 406 bp. (Note: This is a
minimum length of conversion, as it is unknown how far conversion
extended between the polymorphic markers.) The distribution of
silent
mutations incorporated in the GCTs inversely correlated
with distance
from the DSB site, with only the nearby
NsiI site
incorporated in the majority of clones. The GCTs were exclusively
continuous, such that each of the mutations between the outermost
converted restriction site and the
NcoI site was converted.
Overall,
the GCTs derived from intrachromosomal DSB-promoted
recombination
were very similar to those we observed previously in
gene-targeting
experiments (
17).

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 5.
GCTs after DSB-induced intrachromosomal recombination in
cells containing the H-DR-8mu substrate. GCTs were derived from four
independent experiments, and 40 recombinants of each of the wild-type
(A) and Msh2 / (B) cell lines were analyzed.
The pneo-8mu repair template is shown at the top (rectangle), with the
positions of silent mutations and the distances (in base pairs) between
the mutations. When GCTs were being calculated, an additional base pair
was added for the conversion of the silent mutation and 4 bp was added
for the incorporation of the NcoI site. The percent of
recombinants incorporating each silent mutation is shown. This number
is broken down to the percent of recombinants which had partial
restriction cleavage at the site (i.e., mixed) and the percent of
recombinants which had complete cleavage (i.e., fully converted). The
correcting NcoI site occurred in 100% of the
neo+ recombinants as expected, since it restores
a functional gene. The number of recombinants with each of the
indicated GCTs is shown.
|
|
In contrast to recombinants from the wild-type cells, the majority of
recombinants derived from
Msh2
/
cells
frequently had GCTs in which the restriction site polymorphisms
were
incompletely converted (Fig.
5B). Many of the restriction
sites in the
amplified PCR products were only partially cleaved
by one or more
restriction enzymes, indicating that segregation
of unrepaired hDNA had
occurred in these recombinants. This strongly
suggests that in
wild-type cells, hDNA repair is a mechanism of
gene conversion during
DSB repair. Other differences were also
seen between the mutant and
wild-type cells. Taking into account
the partially converted GCTs, only
52% of the GCTs were 58 bp
or less, compared with 80% in the
wild-type cells. The longest
observed GCT was 508 bp, and 1 of the 40 recombinants was found
to have incorporated the most distant
polymorphism,
ApaI, located
487 bp 5' of the
NcoI
site. We have not observed the
ApaI polymorphism
in any of
the 120 GCTs we analyzed from wild-type recombinants
derived from
either intrachromosomal recombination (this report)
or gene targeting
(
17). The most distant 3' polymorphism at
the
PmlI site was also found to be more frequently incorporated
into the
Msh2
/
recombinants. We also for the
first time observed discontinuous
GCTs in three of the
Msh2
/
recombinants. The GCT of one of these
clones, for example, was
converted at the
NcoI and
PmlI sites, but not at the
NsiI
site.
Although restriction site polymorphisms most distant from the DSB site
were more frequently converted in the
Msh2
/
cells, the two closest sites were converted at a frequency similar
to
that in the wild-type cells. When examining these sites to
see if they
were fully converted or partially converted, we found
that many of the
more distant sites were partially converted in
the
Msh2
/
cells, whereas the sites closest to
the DSB site were often fully
converted. That is, the
NsiI
site was fully converted in the majority
of recombinants containing
this site (23 of 33 recombinants);
however, the next closest site,
NruI, was present in 14 recombinants
but was fully converted
in only four of them. The exceptional
long GCT that was fully converted
in the
Msh2
/
cells was 202 bp. The presence
of fully converted restriction
site polymorphisms suggests that gap
repair also contributes to
gene conversion, although less frequently
than hDNA
repair.
Segregation of gene converstion tracts from
Msh2
/
recombinants.
The bidirectional
GCTs from Msh2
/
cells raised the question as
to how the partially converted silent mutations would segregate. That
is, would mutations 5' of the DSB site segregate as a group, and if so,
would this group of mutations segregate away from mutations 3' of the
DSB site or segregate together with 3' mutations? If sequence
information incorporated into hDNA was derived from only one strand of
the repair substrate and this strand spanned the break site, then the
5' and 3' mutations would be expected to segregate together (Fig.
6A). Alternatively, if sequence
information was derived from both DNA strands of the repair substrate,
one strand 5' to the break site and the other 3' to the break site, the
two groups of mutations would be expected to segregate independently.

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 6.
(A) Two mechanisms for the derivation of bidirectional
tracts. (B) Segregation of GCTs from two
Msh2 / intrachromosomal recombinants. Both
recombinants have a bidirectional GCT (i.e., a detectable GCT on both
sides of the NcoI site) that is mixed. After subcloning,
each recombinant yielded two classes of subclones, as shown.
|
|
To address this, we subcloned two
neo+
recombinants, 17-13 and 17-18 (Fig.
6B). Cells from each recombinant
were diluted and
plated into a 96-well plate, and wells were then
examined after
a few days for the growth of a single colony. Subclones
were expanded
for genomic DNA preparation and PCR analysis. The
bidirectional
GCT of recombinant 17-13 can be designated A
m
L
m P
m B
m X
m
Nr

Nc
+ Ns
m, where "m"
indicates mixed (partial) cleavage by the indicated
restriction enzyme,
"+" indicates complete cleavage, and "

" indicates
no
cleavage. Two classes of subclones were identified from this
recombinant. In one class, the genotype was A
+
L
+ P
+ B
+ X
+
Nr

Nc
+, and in the other class it was
Nc
+ Ns
+. The GCT of recombinant 17-18 is the
longest of all of the
neo+ recombinants and is
designated L
m P
m B
m X
m
Nr
+ Nc
+ Ns
+ Pm
m. This
recombinant also gave rise to two classes of subclones.
In this case,
the genotype of one class was L
+ P
+
B
+ X
+ Nr
+ Nc
+
Ns
+ and the genotype of the other class was Nr
+
Nc
+ Ns
+ Pm
+. Since in both
recombinants the mutations segregated independently,
silent
polymorphisms appear to have been incorporated on both
strands of the
hDNA. Presumably, one strand was 5' to the break
site and the other
strand was 3' to the break
site.
 |
DISCUSSION |
We have examined the effect of heterology on DSB-induced
homologous recombination in mammalian cells, comparing wild-type and
Msh2
/
ES cells. We found that in wild-type
cells, the frequency of recombination between diverged sequences in a
gene-targeting assay was reduced as the sequence divergence increased,
consistent with what was previously observed (17), but
that the effect of heterology was significantly overcome in
Msh2
/
cells. Thus, for a plasmid substrate
with 1.5% heterology relative to the chromosomal sequence, DSB-induced
recombination is reduced 17-fold in wild-type cells when normalized to
recombination with a nearly identical substrate, but only 1.7-fold in
Msh2
/
cells. Similar to gene targeting,
DSB-induced intrachromosomal recombination between diverged sequences
was also reduced to a greater extent in wild-type cells than in
Msh2
/
cells. The products of recombination
in the Msh2 mutant were also significantly altered. Most
notably, the majority of GCTs derived from intrachromosomal
recombination had mixed polymorphic markers present in the homologous
repair substrate, implying that hDNA formation followed by MMR
correction is a major mechanism for the conversion of markers near a
DSB in mammalian cells.
These results are in agreement with those previously reported for
mammalian cells in which the barrier to spontaneous recombination between diverged sequences was found to be relaxed in MMR-deficient cells (1, 13, 14). The fold reduction of recombination in
wild-type cells in these experiments was similar to or even greater
than what we saw in the wild-type cells with our most diverged
substrate. However, in our experiments we found that recombination was
not fully restored in the Msh2
/
ES cells,
whereas in the previous reports the barrier to recombination was found
to be almost completely abrogated by Msh2 mutation. This
difference may be attributable to the design of the gene-targeting experiments. Our experiments examined DSB-induced recombination of
small DNA fragments containing single nucleotide substitutions, whereas
the previous experiments investigated recombination in the absence of
induced chromosomal damage using much larger fragments that contained
different types of polymorphisms.
In addition to the frequency of recombination, we have also examined
GCTs in the recombinants derived from the Msh2 mutant cell
line. This is the first time, to our knowledge, that GCTs in mammalian
cells in an MMR-defective background have been studied. For this study,
we examined phenotypically silent mutations spaced every 50 to 100 bp
or less in the repair substrate. DSB repair by gene conversion has been
proposed to occur by two possible mechanisms: (i) hDNA formation
followed by mismatch correction and (ii) gap formation after both
strands adjacent to the DSB are processed. Examination of the GCTs in
cells which lacked MMR activity allowed us to infer which mechanism of
gene conversion was occurring during DSB repair in wild-type cells. We
observed that 55% of Msh2
/
neo+ recombinants had mixed GCTs, which were
predicted by hDNA correction, whereas only 2.5% of the wild-type
recombinants had mixed GCTs. Considering the silent mutations
individually, most mutations when converted were partially converted in
the recombinants (i.e., mixed; Fig. 7),
suggesting that the conversion involved hDNA correction. The mutation
that was the one exception was the one nearest the DSB (the
NsiI site), which is frequently fully converted, even in
Msh2
/
cells. Thus, with the exception of the
mutation at the NsiI site, 39 of 48 (81%) conversion events
involved hDNA formation. The frequency for each mutation depends on the
distance from the DSB site, since mutations at some distance from the
site (
183 bp) were found to be incorporated exclusively by hDNA
correction (Fig. 7).

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 7.
Summary of gene conversion frequencies for each silent
mutation in wild-type and Msh2 / cells. The
conversion frequency for each mutation (Fig. 5) was plotted as a
function of distance from the DSB.
|
|
Gap formation was expected to account for the remaining conversion
events. Fully converted mutations were anticipated to occur in the
Msh2 mutant only if both strands of the DNA adjacent to the
DSB were degraded by nucleases. Information for the repair would then
have come solely from the diverged donor substrate. In three conversion
events, gap formation may have extended 100 bp or more from the DSB.
Gap formation, however, was especially evident at the NsiI
site located 8 bp from the I-SceI site, since it was fully
converted in 70% (58 out of 83; Fig. 5) of the conversion events (Fig.
7). In the remaining events at this site, processing at the DNA ends
led to the loss of the I-SceI site but also to the retention
of nucleotides only 8 bp further away, although it is not clear if the
sequence heterology of the I-SceI site affected the
incorporation of this mutation. In summary, therefore, we infer that
gene conversion occurs primarily by hDNA correction, but that sequences
near the DSB can be incorporated by gap formation, the frequency
depending on the distance from the DSB. These results are generally in
good agreement with those obtained with yeast, in which it has been
found that sequences close to the end of a DSB are preserved during
gene conversion (22, 44, 58), although the results here
suggest that there may be somewhat more nibbling of ends in mammalian
cells. Evidence for hDNA correction during DSB-promoted and spontaneous
gene conversion in wild-type mammalian cells has previously been
obtained using palindromic markers which are not efficiently repaired
by MMR (15, 30, 31). However, some other aspects of the
GCTs (i.e., length and discontinuity) differ from results obtained here
with single polymorphisms.
Current models for mitotic gene conversion favor mechanisms in which
recombination is coupled to replication (3, 19, 24, 38, 40,
46). In these models, a 3' end invades the unbroken homologous
template and initiates repair synthesis. The newly synthesized strand
is then incorporated into the broken molecule, which can result in hDNA
formation. In principle, invasion of either one or both 3' ends
flanking the DSB could initiate repair synthesis. Our bidirectional
GCTs are consistent with invasion of the template from both 3' ends,
since markers on each side of the DSB segregate at the next cell
division (Fig. 6), as would be expected from hDNA formation involving
opposite strands. The majority of recombinants (27 out of 40; 68%) did
not show bidirectional tracts, however. In these cases, two-ended
invasion may have occurred but may not have incorporated the
polymorphic markers. Alternatively, one-ended invasion may have
occurred, as has been proposed for other mammalian gene conversion
events (24, 46).
Our results also indicate a trend toward longer GCTs in the
Msh2 mutant. In 80% of the wild-type recombinants, the
observed GCTs were 58 bp or less, consistent with previous results
(17), whereas in the Msh2
/
recombinants, only 52% of GCTs were as short. We saw a sixfold increase in the Msh2
/
cells in GCTs
extending to the most distant 3' polymorphism from the break site,
PmlI. We also saw for the first time the incorporation of
the most distant 5' polymorphism, ApaI, in one of the mutant recombinants. The mean observed GCT was also found to be somewhat longer (by 20%) in Msh2
/
cells than in
wild-type cells. Two mechanisms could account for the longer GCTs: (i)
MMR proteins may regulate the length of hDNA formation, as suggested
previously (7), or (ii) the length of hDNA is the same,
but in wild-type cells, correction of hDNA at a distance from the DSB
is in favor of the recipient DNA molecule rather than the donor.
Support for the latter mechanism is that the strand copied from the
donor molecule would be expected to be broken at the end of the hDNA
tract, and strand breaks are known to influence the direction of
mismatch correction. Nevertheless, in bacteria, MMR proteins have been
shown to inhibit RecA-catalyzed strand transfer (59),
consistent with a direct effect on hDNA length.
In MMR-deficient bacteria, gross chromosomal rearrangements involving
diverged DNA are increased as a result of the recombinator phenotype of
these mutants (43). Results in this report, as well as
those previously published, demonstrate that MMR-deficient mammalian
cells also have increased recombination as a result of a relaxation of
recombination between diverged sequences. These results would seem to
predict that MMR-deficient mammalian cells, like bacteria, would
exhibit frequent gross chromosomal rearrangements. Surprisingly, tumors
derived from HNPCC patients are generally euploid and do not display
gross chromosomal structure defects, even while cell lines from
sporadic tumors show continuous chromosomal instability (reference
4 and references therein; 18, 28). Possibly,
more subtle chromosomal rearrangements than those that would be
apparent from chromosome number analyses are present in MMR-deficient
cells but have yet to be detected.
Nevertheless, several factors may contribute to the maintenance of a
normal genotype in cells with MMR deficiency. First, the barrier to
recombination between diverged elements is not completely overcome.
Although DSBs induce the highest levels of recombination detected thus
far (32), DSB-induced recombination between sequences that
are only 1.5% diverged are still not fully restored, even with
MMR mutation. Considering that repetitive elements in mammalian genomes
are often significantly more diverged (e.g., an average of 15% for
Alu elements; 51), recombination between
highly diverged elements is predicted to be suppressed at least
partially in MMR-deficient cells. Second, the outcome of DSB-induced
recombination in mammalian cells has a strong bias towards noncrossover
events (24, 46). Therefore, recombination between
repetitive elements would not be predicted to have a discernible outcome in most instances because there would not be an exchange of
flanking markers. Third, in addition to having a role in recombination between diverged sequences, MMR proteins in yeast are known to have a
second role in recombination, such that their mutation would decrease
recombination instead of leading to its enhancement. This role involves
the removal of nonhomologous tails which are 30 nucleotides or longer
and which are formed during some types of recombination (41, 49,
55). Because dispersed repetitive elements are flanked by DNA
which is not homologous, initiation of recombination outside two
dispersed elements, unlike the events assayed in this report, is likely
to lead to the formation of nonhomologous tails involving the flanking
DNA. Although this role for MMR proteins has yet to be demonstrated in
mammalian cells, efficient removal of these tails in yeast requires
Msh2 (41, 49, 55), suggesting that recombination between
dispersed elements could be reduced by Msh2 mutation.
Despite these multiple levels of control that maintain chromosome
integrity in MMR-deficient cells, the experiments presented here
nevertheless demonstrate that these cells have a recombinator phenotype
for DSB-induced events, raising the possibility that these cells
undergo promiscuous recombination at some level. Although tumorigenesis
in HNPCC has been clearly linked to the mutator phenotype arising from
an inability to repair replication errors (20),
recombination between diverged sequences in MMR-deficient cells may
contribute to the genomic alterations important for the development of
the disease. Additional experiments will be necessary to further
delineate the effect of MMR mutation on homologous recombination in
mammalian cells.
 |
ACKNOWLEDGMENTS |
We thank Hein te Riele (Amsterdam, The Netherlands) for the
Msh2 mutant cell line and Roger Johnson and other members of
the Jasin laboratory.
B.E. was supported by an NRSA fellowship (GM18831). This work was
supported by NIH (GM54688) and NSF (MCB-9728333) grants to M.J.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Cell Biology
Program, Memorial Sloan-Kettering Cancer Center and Cornell University Graduate School of Medical Sciences, 1275 York Ave., New York, NY
10021. Phone: (212) 639-7438. Fax: (212) 717-3317. E-mail: m-jasin{at}ski.mskcc.org.
 |
REFERENCES |
| 1.
|
Abuin, A.,
H. Zhang, and A. Bradley.
2000.
Genetic analysis of mouse embryonic stem cells bearing Msh3 and Msh2 single and compound mutations.
Mol. Cell. Biol.
20:149-157[Abstract/Free Full Text].
|
| 2.
|
Acharya, S.,
T. Wilson,
S. Gradia,
M. F. Kane,
S. Guerrette,
G. T. Marsischky,
R. Kolodner, and R. Fishel.
1996.
hMSH2 forms specific mispair-binding complexes with hMSH3 and hMSH6.
Proc. Natl. Acad. Sci. USA
93:13629-13634[Abstract/Free Full Text].
|
| 3.
|
Belmaaza, A., and P. Chartrand.
1994.
One-sided invasion events in homologous recombination at double-strand breaks.
Mutat. Res.
314:199-208[Medline].
|
| 4.
|
Bocker, T.,
J. Schlegel,
F. Kullmann,
G. Stumm,
H. Zirngibl,
J. T. Epplen, and J. Ruschoff.
1996.
Genomic instability in colorectal carcinomas: comparison of different evaluation methods and their biological significance.
J. Pathol.
179:15-19[CrossRef][Medline].
|
| 5.
|
Boland, C. R.
1998.
Hereditary nonpolyposis colorectal cancer, p. 333-346.
In
B. Vogelstein, and K. W. Kinzler (ed.), The genetic basis of human cancer. McGraw-Hill, New York, N.Y.
|
| 6.
|
Buermeyer, A. B.,
S. M. Deschenes,
S. M. Baker, and R. M. Liskay.
1999.
Mammalian DNA mismatch repair.
Annu. Rev. Genet.
33:533-564[CrossRef][Medline].
|
| 7.
|
Chen, W., and S. Jinks-Robertson.
1998.
Mismatch repair proteins regulate heteroduplex formation during mitotic recombination in yeast.
Mol. Cell. Biol.
18:6525-6537[Abstract/Free Full Text].
|
| 8.
|
Chen, W., and S. Jinks-Robertson.
1999.
The role of the mismatch repair machinery in regulating mitotic and meiotic recombination between diverged sequences in yeast.
Genetics
151:1299-1313[Abstract/Free Full Text].
|
| 9.
|
Cooper, D. N.,
M. Krawczak, and S. E. Antonarkis.
1998.
The nature and mechanisms of human gene mutation, p. 65-94.
In
B. Vogelstein, and K. W. Kinzler (ed.), The genetic basis of human cancer. McGraw-Hill, New York, N.Y.
|
| 10.
|
Datta, A.,
A. Adjiri,
L. New,
G. F. Crouse, and S. Jinks Robertson.
1996.
Mitotic crossovers between diverged sequences are regulated by mismatch repair proteins in Saccharomyces cerevisiae.
Mol. Cell. Biol.
16:1085-1093[Abstract].
|
| 11.
|
Datta, A.,
M. Hendrix,
M. Lipsitch, and S. Jinks-Robertson.
1997.
Dual roles for DNA sequence identity and the mismatch repair system in the regulation of mitotic crossing-over in yeast.
Proc. Natl. Acad. Sci. USA
94:9757-9762[Abstract/Free Full Text].
|
| 12.
|
de Laat, W. L.,
N. G. Jaspers, and J. H. Hoeijmakers.
1999.
Molecular mechanism of nucleotide excision repair.
Genes Dev.
13:768-785[Free Full Text].
|
| 13.
|
de Wind, N.,
M. Dekker,
A. Berns,
M. Radman, and H. te Riele.
1995.
Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer.
Cell
82:321-330[CrossRef][Medline].
|
| 14.
|
de Wind, N.,
M. Dekker,
N. Claij,
L. Jansen,
Y. van Klink,
M. Radman,
G. Riggins,
M. van der Valk,
K. van't Wout, and H. te Riele.
1999.
HNPCC-like cancer predisposition in mice through simultaneous loss of Msh3 and Msh6 mismatch-repair protein functions.
Nat. Genet.
23:359-362[CrossRef][Medline].
|
| 15.
|
Donoho, G.,
M. Jasin, and P. Berg.
1998.
Analysis of gene targeting and intrachromosomal homologous recombination stimulated by genomic double-strand breaks in mouse embryonic stem cells.
Mol. Cell. Biol.
18:4070-4078[Abstract/Free Full Text].
|
| 16.
|
Drummond, J. T.,
G. M. Li,
M. J. Longley, and P. Modrich.
1995.
Isolation of an hMSH2-p160 heterodimer that restores DNA mismatch repair to tumor cells.
Science
268:1909-1912[Abstract/Free Full Text].
|
| 17.
|
Elliott, B.,
C. Richardson,
J. Winderbaum,
J. A. Nickoloff, and M. Jasin.
1998.
Gene conversion tracts from double-strand break repair in mammalian cells.
Mol. Cell. Biol.
18:93-101[Abstract/Free Full Text].
|
| 18.
|
Eshleman, J. R.,
G. Casey,
M. E. Kochera,
W. D. Sedwick,
S. E. Swinler,
M. L. Veigl,
J. K. Willson,
S. Schwartz, and S. D. Markowitz.
1998.
Chromosome number and structure both are markedly stable in RER colorectal cancers and are not destabilized by mutation of p53.
Oncogene
17:719-725[CrossRef][Medline].
|
| 19.
|
Ferguson, D. O., and W. K. Holloman.
1996.
Recombinational repair of gaps in DNA is asymmetric in Ustilago maydis and can be explained by a migrating D-loop model.
Proc. Natl. Acad. Sci. USA
93:5419-5424[Abstract/Free Full Text].
|
| 20.
|
Gurin, C. C.,
M. G. Federici,
L. Kang, and J. Boyd.
1999.
Causes and consequences of microsatellite instability in endometrial carcinoma.
Cancer Res.
59:462-466[Abstract/Free Full Text].
|
| 21.
|
Haber, J. E.
1999.
DNA repair. Gatekeepers of recombination.
Nature
398:665[CrossRef][Medline], 667.
|
| 22.
|
Haber, J. E.,
B. L. Ray,
J. M. Kolb, and C. I. White.
1993.
Rapid kinetics of mismatch repair of heteroduplex DNA that is formed during recombination in yeast.
Proc. Natl. Acad. Sci. USA
90:3363-3367[Abstract/Free Full Text].
|
| 23.
|
Hanahan, D., and R. A. Weinberg.
2000.
The hallmarks of cancer.
Cell
100:57-70[CrossRef][Medline].
|
| 24.
|
Johnson, R. D., and M. Jasin.
2000.
Sister chromatid gene conversion is a prominent double-strand break repair pathway in mammalian cells.
EMBO J.
19:3398-3407[CrossRef][Medline].
|
| 25.
|
Johnson, R. E.,
G. K. Kovvali,
L. Prakash, and S. Prakash.
1996.
Requirement of the yeast MSH3 and MSH6 genes for MSH2-dependent genomic stability.
J. Biol. Chem.
271:7285-7288[Abstract/Free Full Text].
|
| 26.
|
Lacalle, R. A.,
D. Pulido,
J. Vara,
M. Zalacain, and A. Jimenez.
1989.
Molecular analysis of the pac gene encoding a puromycin N-acetyl transferase from Streptomyces alboniger.
Gene
79:375-380[CrossRef][Medline].
|
| 27.
|
Lengauer, C.,
K. W. Kinzler, and B. Vogelstein.
1998.
Genetic instabilities in human cancers.
Nature
396:643-649[CrossRef][Medline].
|
| 28.
|
Lengauer, C.,
K. W. Kinzler, and B. Vogelstein.
1997.
Genetic instability in colorectal cancers.
Nature
386:623-627[CrossRef][Medline].
|
| 29.
|
Leung, W.,
A. Malkova, and J. E. Haber.
1997.
Gene targeting by linear duplex DNA frequently occurs by assimilation of a single strand that is subject to preferential mismatch correction.
Proc. Natl. Acad. Sci. USA
94:6851-6856[Abstract/Free Full Text].
|
| 30.
|
Li, J., and M. D. Baker.
2000.
Use of a small palindrome genetic marker to investigate mechanisms of double-strand-break repair in mammalian cells.
Genetics
154:1281-1289[Abstract/Free Full Text].
|
| 31.
|
Li, J.,
L. R. Read, and M. D. Baker.
2001.
The mechanism of mammalian gene replacement is consistent with the formation of long regions of heteroduplex DNA associated with two crossing-over events.
Mol. Cell. Biol.
21:501-510[Abstract/Free Full Text].
|
| 32.
|
Liang, F.,
M. Han,
P. J. Romanienko, and M. Jasin.
1998.
Homology-directed repair is a major double-strand break repair pathway in mammalian cells.
Proc. Natl. Acad. Sci. USA
95:5172-5177[Abstract/Free Full Text].
|
| 33.
|
Liang, F.,
P. J. Romanienko,
D. T. Weaver,
P. A. Jeggo, and M. Jasin.
1996.
Chromosomal double-strand break repair in Ku80-deficient cells.
Proc. Natl. Acad. Sci. USA
93:8929-8933[Abstract/Free Full Text].
|
| 34.
|
Loeb, L. A.
1991.
Mutator phenotype may be required for multistage carcinogenesis.
Cancer Res.
51:3075-3079[Free Full Text].
|
| 35.
|
Marsischky, G. T.,
N. Filosi,
M. F. Kane, and R. Kolodner.
1996.
Redundancy of Saccharomyces cerevisiae MSH3 and MSH6 in MSH2-dependent mismatch repair.
Genes Dev.
10:407-420[Abstract/Free Full Text].
|
| 36.
|
McGill, C.,
B. Shafer, and J. Strathern.
1989.
Coconversion of flanking sequences with homothallic switching.
Cell
57:459-467[CrossRef][Medline].
|
| 37.
|
Modrich, P., and R. Lahue.
1996.
Mismatch repair in replication fidelity, genetic recombination, and cancer biology.
Annu. Rev. Biochem.
65:101-133[CrossRef][Medline].
|
| 38.
|
Nassif, N.,
J. Penney,
S. Pal,
W. R. Engels, and G. B. Gloor.
1994.
Efficient copying of nonhomologous sequences from ectopic sites via P-element-induced gap repair.
Mol. Cell. Biol.
14:1613-1625[Abstract/Free Full Text].
|
| 39.
|
Negritto, M. T.,
X. Wu,
T. Kuo,
S. Chu, and A. M. Bailis.
1997.
Influence of DNA sequence identity on efficiency of targeted gene replacement.
Mol. Cell. Biol.
17:278-286[Abstract].
|
| 40.
|
Pâques, F., and J. E. Haber.
1999.
Multiple pathways of recombination induced by double-strand breaks in Saccharomyces cerevisiae.
Microbiol. Mol. Biol. Rev.
63:349-404[Abstract/Free Full Text].
|
| 41.
|
Pâques, F., and J. E. Haber.
1997.
Two pathways for removal of nonhomologous DNA ends during double-strand break repair in Saccharomyces cerevisiae.
Mol. Cell. Biol.
17:6765-6771[Abstract].
|
| 42.
|
Petes, T. D.,
R. E. Malone, and L. S. Symington.
1991.
Recombination in yeast, p. 407-521.
In
J. R. Broach, J. R. Pringle, and E. W. Jones (ed.), The molecular and cellular biology of the yeast Saccharomyces: genome dynamics, protein synthesis, and energetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 43.
|
Petit, M. A.,
J. Dimpfl,
M. Radman, and H. Echols.
1991.
Control of large chromosomal duplications in Escherichia coli by the mismatch repair system.
Genetics
129:327-332[Abstract].
|
| 44.
|
Ray, B. L.,
C. I. White, and J. E. Haber.
1991.
Heteroduplex formation and mismatch repair of the "stuck" mutation during mating-type switching in Saccharomyces cerevisiae.
Mol. Cell. Biol.
11:5372-5380[Abstract/Free Full Text].
|
| 45.
|
Rayssiguier, C.,
D. S. Thaler, and M. Radman.
1989.
The barrier to recombination between Escherichia coli and Salmonella typhimurium is disrupted in mismatch-repair mutants.
Nature
342:396-401[CrossRef][Medline].
|
| 46.
|
Richardson, C.,
M. E. Moynahan, and M. Jasin.
1998.
Double-strand break repair by interchromosomal recombination: suppression of chromosomal translocations.
Genes Dev.
12:3831-3842[Abstract/Free Full Text].
|
| 47.
|
Robertson, E. J.
1987.
Embryo-derived stem cell lines, p. 71-112.
In
E. J. Robertson (ed.), Teratocarcinomas and embryonic stem cells: a practical approach. IRL Press, Washington, D.C.
|
| 48.
|
Rouet, P.,
F. Smith, and M. Jasin.
1994.
Introduction of double-strand breaks into the genome of mouse cells by expression of a rare-cutting endonuclease.
Mol. Cell. Biol.
14:8096-8106[Abstract/Free Full Text].
|
| 49.
|
Saparbaev, M.,
L. Prakash, and S. Prakash.
1996.
Requirement of mismatch repair genes MSH2 and MSH3 in the RAD1-RAD10 pathway of mitotic recombination in Saccharomyces cerevisiae.
Genetics
142:727-736[Abstract].
|
| 50.
|
Sargent, R. G.,
M. A. Brenneman, and J. H. Wilson.
1997.
Repair of site-specific double-strand breaks in a mammalian chromosome by homologous and illegitimate recombination.
Mol. Cell. Biol.
17:267-277[Abstract].
|
| 51.
|
Schmid, C. W.
1996.
Alu: structure, origin, evolution, significance and function of one-tenth of human DNA.
Prog. Nucleic Acid Res. Mol. Biol.
53:283-319[Medline].
|
| 52.
|
Selva, E. M.,
L. New,
G. F. Crouse, and R. S. Lahue.
1995.
Mismatch correction acts as a barrier to homeologous recombination in Saccharomyces cerevisiae.
Genetics
139:1175-1188[Abstract].
|
| 53.
|
Smih, F.,
P. Rouet,
P. J. Romanienko, and M. Jasin.
1995.
Double-strand breaks at the target locus stimulate gene targeting in embryonic stem cells.
Nucleic Acids Res.
23:5012-5019[Abstract/Free Full Text].
|
| 54.
|
Strout, M. P.,
G. Marcucci,
C. D. Bloomfield, and M. A. Caligiuri.
1998.
The partial tandem duplication of ALL1 (MLL) is consistently generated by Alu-mediated homologous recombination in acute myeloid leukemia.
Proc. Natl. Acad. Sci. USA
95:2390-2395[Abstract/Free Full Text].
|
| 55.
|
Sugawara, N.,
F. Pâques,
M. Colaiacovo, and J. E. Haber.
1997.
Role of Saccharomyces cerevisiae Msh2 and Msh3 repair proteins in double-strand break-induced recombination.
Proc. Natl. Acad. Sci. USA
94:9214-9921[Abstract/Free Full Text].
|
| 56.
|
Taghian, D. G., and J. A. Nickoloff.
1997.
Chromosomal double-strand breaks induce gene conversion at high frequency in mammalian cells.
Mol. Cell. Biol.
17:6386-6393[Abstract].
|
| 57.
|
Thomas, K. R., and M. R. Capecchi.
1987.
Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells.
Cell
51:503-512[CrossRef][Medline].
|
| 58.
|
Weng, Y. S., and J. A. Nickoloff.
1998.
Evidence for independent mismatch repair processing on opposite sides of a double-strand break in Saccharomyces cerevisiae.
Genetics
148:59-70[Abstract/Free Full Text].
|
| 59.
|
Worth, L., Jr.,
S. Clark,
M. Radman, and P. Modrich.
1994.
Mismatch repair proteins MutS and MutL inhibit RecA-catalyzed strand transfer between diverged DNAs.
Proc. Natl. Acad. Sci. USA
91:3238-3241[Abstract/Free Full Text].
|
Molecular and Cellular Biology, April 2001, p. 2671-2682, Vol. 21, No. 8
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.8.2671-2682.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Kappeler, M., Kranz, E., Woolcock, K., Georgiev, O., Schaffner, W.
(2008). Drosophila bloom helicase maintains genome integrity by inhibiting recombination between divergent DNA sequences. Nucleic Acids Res
36: 6907-6917
[Abstract]
[Full Text]
-
Hong, Z., Jiang, J., Hashiguchi, K., Hoshi, M., Lan, L., Yasui, A.
(2008). Recruitment of mismatch repair proteins to the site of DNA damage in human cells. J. Cell Sci.
121: 3146-3154
[Abstract]
[Full Text]
-
Smith, J. A., Bannister, L. A., Bhattacharjee, V., Wang, Y., Waldman, B. C., Waldman, A. S.
(2007). Accurate Homologous Recombination Is a Prominent Double-Strand Break Repair Pathway in Mammalian Chromosomes and Is Modulated by Mismatch Repair Protein Msh2. Mol. Cell. Biol.
27: 7816-7827
[Abstract]
[Full Text]
-
Neuwirth, E. A. H., Honma, M., Grosovsky, A. J.
(2007). Interchromosomal Crossover in Human Cells Is Associated with Long Gene Conversion Tracts. Mol. Cell. Biol.
27: 5261-5274
[Abstract]
[Full Text]
-
Barwell, J, Pangon, L, Hodgson, S, Georgiou, A, Kesterton, I, Slade, T, Taylor, M, Payne, S J, Brinkman, H, Smythe, J, Sebire, N J, Solomon, E, Docherty, Z, Camplejohn, R, Homfray, T, Morris, J R
(2007). Biallelic mutation of MSH2 in primary human cells is associated with sensitivity to irradiation and altered RAD51 foci kinetics. J. Med. Genet.
44: 516-520
[Abstract]
[Full Text]
-
Flanagan, S. A., Robinson, B. W., Krokosky, C. M., Shewach, D. S.
(2007). Mismatched nucleotides as the lesions responsible for radiosensitization with gemcitabine: a new paradigm for antimetabolite radiosensitizers. Molecular Cancer Therapeutics
6: 1858-1868
[Abstract]
[Full Text]
-
Yang, D., Goldsmith, E. B., Lin, Y., Waldman, B. C., Kaza, V., Waldman, A. S.
(2006). Genetic Exchange Between Homeologous Sequences in Mammalian Chromosomes Is Averted by Local Homology Requirements for Initiation and Resolution of Recombination. Genetics
174: 135-144
[Abstract]
[Full Text]
-
Trouiller, B., Schaefer, D. G., Charlot, F., Nogue, F.
(2006). MSH2 is essential for the preservation of genome integrity and prevents homeologous recombination in the moss Physcomitrella patens. Nucleic Acids Res
34: 232-242
[Abstract]
[Full Text]
-
Muntoni, A., Reddel, R. R.
(2005). The first molecular details of ALT in human tumor cells. Hum Mol Genet
14: R191-R196
[Abstract]
[Full Text]
-
TUTT, A.N.J., LORD, C.J., MCCABE, N., FARMER, H., TURNER, N., MARTIN, N.M., JACKSON, S.P., SMITH, G.C.M., ASHWORTH, A.
(2005). Exploiting the DNA Repair Defect in BRCA Mutant Cells in the Design of New Therapeutic Strategies for Cancer. Cold Spring Harb Symp Quant Biol
70: 139-148
[Abstract]
-
Yun, S., Lie-A-Cheong, C., Porter, A. C. G.
(2004). Discriminatory suppression of homologous recombination by p53. Nucleic Acids Res
32: 6479-6489
[Abstract]
[Full Text]
-
Stark, J. M., Pierce, A. J., Oh, J., Pastink, A., Jasin, M.
(2004). Genetic Steps of Mammalian Homologous Repair with Distinct Mutagenic Consequences. Mol. Cell. Biol.
24: 9305-9316
[Abstract]
[Full Text]
-
Chen, F., Arseven, O. K., Cryns, V. L.
(2004). Proteolysis of the Mismatch Repair Protein MLH1 by Caspase-3 Promotes DNA Damage-induced Apoptosis. J. Biol. Chem.
279: 27542-27548
[Abstract]
[Full Text]
-
Molinier, J., Ramos, C., Fritsch, O., Hohn, B.
(2004). CENTRIN2 Modulates Homologous Recombination and Nucleotide Excision Repair in Arabidopsis. Plant Cell
16: 1633-1643
[Abstract]
[Full Text]
-
Bechter, O. E., Zou, Y., Walker, W., Wright, W. E., Shay, J. W.
(2004). Telomeric Recombination in Mismatch Repair Deficient Human Colon Cancer Cells after Telomerase Inhibition. Cancer Res.
64: 3444-3451
[Abstract]
[Full Text]
-
Read, L. R., Raynard, S. J., Ruksc, A., Baker, M. D.
(2004). Gene repeat expansion and contraction by spontaneous intrachromosomal homologous recombination in mammalian cells. Nucleic Acids Res
32: 1184-1196
[Abstract]
[Full Text]
-
Han, J., Hankinson, S. E., Hunter, D. J., De Vivo, I.
(2004). Genetic Variations in XRCC2 and XRCC3 Are Not Associated with Endometrial Cancer Risk. Cancer Epidemiol. Biomarkers Prev.
13: 330-331
[Full Text]
-
Bell, J. S., McCulloch, R.
(2003). Mismatch Repair Regulates Homologous Recombination, but Has Little Influence on Antigenic Variation, in Trypanosoma brucei. J. Biol. Chem.
278: 45182-45188
[Abstract]
[Full Text]
-
Villemure, J.-F., Abaji, C., Cousineau, I., Belmaaza, A.
(2003). MSH2-deficient Human Cells Exhibit a Defect in the Accurate Termination of Homology-directed Repair of DNA Double-Strand Breaks. Cancer Res.
63: 3334-3339
[Abstract]
[Full Text]
-
Hendricks, C. A., Almeida, K. H., Stitt, M. S., Jonnalagadda, V. S., Rugo, R. E., Kerrison, G. F., Engelward, B. P.
(2003). Spontaneous mitotic homologous recombination at an enhanced yellow fluorescent protein (EYFP) cDNA direct repeat in transgenic mice. Proc. Natl. Acad. Sci. USA
100: 6325-6330
[Abstract]
[Full Text]
-
McCulloch, R. D., Read, L. R., Baker, M. D.
(2003). Strand Invasion and DNA Synthesis From the Two 3' Ends of a Double-Strand Break in Mammalian Cells. Genetics
163: 1439-1447
[Abstract]
[Full Text]
-
Stark, J. M., Jasin, M.
(2003). Extensive Loss of Heterozygosity Is Suppressed during Homologous Repair of Chromosomal Breaks. Mol. Cell. Biol.
23: 733-743
[Abstract]
[Full Text]
-
Raynard, S. J., Baker, M. D.
(2002). Incorporation of Large Heterologies Into Heteroduplex DNA During Double-Strand-Break Repair in Mouse Cells. Genetics
162: 977-985
[Abstract]
[Full Text]
-
Mohindra, A., Hays, L. E., Phillips, E. N., Preston, B. D., Helleday, T., Meuth, M.
(2002). Defects in homologous recombination repair in mismatch-repair-deficient tumour cell lines. Hum Mol Genet
11: 2189-2200
[Abstract]
[Full Text]
-
Qin, J., Baker, S., Te Riele, H., Liskay, R. M., Arnheim, N.
(2002). Evidence for the Lack of Mismatch-Repair Directed Antirecombination During Mouse Meiosis. J Hered
93: 201-205
[Abstract]
[Full Text]
-
Cervantes, R. B., Stringer, J. R., Shao, C., Tischfield, J. A., Stambrook, P. J.
(2002). Embryonic stem cells and somatic cells differ in mutation frequency and type. Proc. Natl. Acad. Sci. USA
99: 3586-3590
[Abstract]
[Full Text]
-
Karran, P.
(2001). Mechanisms of tolerance to DNA damaging therapeutic drugs. Carcinogenesis
22: 1931-1937
[Abstract]
[Full Text]
-
Chen, S., Bigner, S. H., Modrich, P.
(2001). High rate of CAD gene amplification in human cells deficient in MLH1 or MSH6. Proc. Natl. Acad. Sci. USA
98: 13802-13807
[Abstract]
[Full Text]
-
Pichierri, P., Franchitto, A., Piergentili, R., Colussi, C., Palitti, F.
(2001). Hypersensitivity to camptothecin in MSH2 deficient cells is correlated with a role for MSH2 protein in recombinational repair. Carcinogenesis
22: 1781-1787
[Abstract]
[Full Text]